The PI3K/AKT pathway in the pathogenesis of prostate cancer.

Huixing Chen, Lan Zhou, Xiaorong Wu, Rongbing Li, Jiling Wen, Jianjun Sha, Xiaofei Wen

Journal: Frontiers in bioscience (Landmark edition) 2017;21(5):1084-91

PMID: 27100493

Abstract

Despite recent advances in our understanding of the biological behavior of prostate cancer (PCa), PCa is becoming the most common malignancy in men worldwide. The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in prostate carcinogenesis. Inflammatory cytokines (CCR9, IL-6, and TLR3) regulate PI3K/AKT signaling during apoptosis of PCa cells, and PI3K/AKT signaling participates with androgen-, 1alpha,25(OH)2-vitamin D3-, and prostaglandin-associated mechanisms and is regulated by ErbB, EGFR, and the HER family during cell growth. During metastasis of PCa cells, the PI3K/AKT/NF-kappaB/BMP-2-Smad axis, PTEN/PI3K/AKT pathway, and PI3K/AKT/mTOR signaling regulates tumor cell metastasis and invasion. The present review focuses on the PI3K/AKT signal pathway and discusses the role of the PI3K/AKT signal pathway in PCa tumorigenesis.

Address: Department of Urology, Shanghai Eastern Hospital, Shanghai, China and Department of Urology, RenJi Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Department of Urology, Shanghai Eastern Hospital, Shanghai, China.; Department of Urology, RenJi Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Department of Urology, Shanghai Eastern Hospital, Shanghai, China, [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.